NCT06361082

Brief Summary

This study explores ultrasonic scattering imaging technology in patients undergoing anterior cruciate ligament (ACL) reconstruction and those with shoulder musculoskeletal disorders. Ultrasonography, widely utilized for diagnosing musculoskeletal conditions, faces limitations due to factors like operator experience and equipment settings, often lacking in quantifiable disease metrics. Nakagami imaging, employing the backscattering statistical distribution model, offers a quantitative assessment method that minimizes subjective interpretation by extracting tissue properties through the interaction between ultrasound and tissue microstructure. The Nakagami model effectively describes tissue scattering statistics, enabling the identification and classification of tissue features based on specific scattering conditions. ACL reconstruction is commonly performed, with postoperative complications including joint stiffness and muscle strength decline, associated with changes in muscle quality and volume. Similarly, soft tissue injuries around the shoulder and ankle are prevalent in sports medicine, with ultrasound used to assess the severity of injuries to soft tissues such as the rotator cuff tendons/muscles and surrounding ligaments of the shoulder, as well as the medial and lateral ligament complexes of the ankle. Preliminary findings suggest that Nakagami imaging can differentiate layers within normal tendons, proposing its potential for visualizing and quantifying soft tissue lesions post-ultrasound, aiming for standardized diagnostic criteria. The results of this project could significantly improve the diagnostic efficacy of musculoskeletal ultrasound, facilitating earlier treatment and reducing the socio-economic impacts. Academically, it positions the investigating team as pioneers in the application of ultrasound inverse scattering imaging technology.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

April 11, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

March 15, 2024

Last Update Submit

April 7, 2024

Conditions

Keywords

Musculoskeletal ultrasoundultrasoundBack-scatteringACL reconstructionACL injury

Outcome Measures

Primary Outcomes (2)

  • MRI of affected limb- Cross sectional area measured in squared cm of quadriceps muscles

    MRI of affected limb will be done, to measure quadriceps muscle cross sectional area in with unit of squared centimeters.

    0-6-12 weeks

  • Ultrasound Nakagami back scattering analysis- Nakagami index

    Ultrasound of affected limb will be done, to calculate Nakagami. A back-scattering analysis algorithm will be applied to derive Nakagami index to give an innovative quantitative assessment of MSK ultrasound. This index as a pure numer index with no unut.

    0-6-12 weeks

Secondary Outcomes (5)

  • Physical examination of limbs- Angles of Range of Motion of knee

    0-6-12 weeks

  • MRI of affected limb- Quality of knee structures documented with descriptions for MR signals

    0-6-12 weeks

  • Physical examination of limbs- Laxity of knee ligaments of subjects number with any positive knee physical findings

    0-6-12 weeks

  • Ultrasound of affected limb- Cross sectional area measured in squared cm of quadriceps muscles

    0-6-12 weeks

  • Ultrasound of affected limb- Quality of knee structures documented with descriptions for echogenicity

    0-6-12 weeks

Study Arms (2)

Non-ACLR Control Group

NO INTERVENTION

Control group arm. Subjects In this arm will receive MRI and ultrasound examination, without receiving any treatment.

ACLR Intervention Arm

EXPERIMENTAL

Intervention group arm. Subjects In this arm will receive MRI and ultrasound examination, before and after receiving ACL reconstruction.

Procedure: ACL reconstruction

Interventions

ACL reconstruction

ACLR Intervention Arm

Eligibility Criteria

Age20 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 20 and above
  • Experimental group: Individuals with tendon, ligament, or nerve disorders around the shoulder joint
  • Control group: Individuals with similar age and gender as the experimental group, confirmed by ultrasound and MRI to have no known diseases of the shoulder tendons, ligaments, or nerves

You may not qualify if:

  • Individuals with a history of injury or disease in the area to be tested: such as fractures, tendon, ligament, or nerve disorders
  • Vulnerable groups: such as pregnant women, children, individuals with mental illness, inmates, etc.
  • Individuals who cannot communicate in Chinese
  • Individuals with poor compliance or obvious mental status abnormalities, or for any reason unable to cooperate with completing clinical symptom interviews, physical examinations, ultrasound examinations, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2024

First Posted

April 11, 2024

Study Start

April 1, 2024

Primary Completion

October 1, 2024

Study Completion

October 1, 2025

Last Updated

April 11, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share